BHASKARA RAO JASTI
Pharmacy in Stockton, CA
License number
Michigan 5302032197
Issued Date
Dec 14, 1998
Expiration Date
Jun 30, 2007
Category
Pharmacy
Type
Pharmacist - Ed Ltd
Address
Address
Stockton, CA 95219
Personal information
See more information about BHASKARA RAO JASTI at radaris.comName
Address
Phone
5032 Bay View Cir, Stockton, CA 95219
1107 2Nd Ave, Redwood City, CA 94063
1107 2Nd Ave, Redwood City, CA 94063
5032 Bay View Cir, Stockton, CA 95219
Professional information
See more information about BHASKARA RAO JASTI at trustoria.com
Ocular Agent Delivery Systems
Ocular Agent Delivery Systems
US Patent:
2008013, Jun 5, 2008
Filed:
Sep 29, 2005
Appl. No.:
11/663608
Inventors:
Xiaoling Li - Danville CA, US
Bhaskara Jasti - Stockton CA, US
Ravichandran Mahalingam - Stockton CA, US
Bhaskara Jasti - Stockton CA, US
Ravichandran Mahalingam - Stockton CA, US
International Classification:
A61K 47/30, A61K 38/02, A61K 47/36, A61K 47/44, A61P 27/00, A61K 47/38, A61K 38/13
US Classification:
514 11, 5147723, 514 2, 514781, 514780, 514777, 514779
Abstract:
This invention is directed to novel ocular agent delivery systems and, in particular, emulsions and molecular dispersions in the form of a gel comprising a hydrophobic ocular agent.
Liposomal Nanoparticles And Other Formulations Of Fenretinide For Use In Therapy And Drug Delivery
Liposomal Nanoparticles And Other Formulations Of Fenretinide For Use In Therapy And Drug Delivery
US Patent:
2012009, Apr 19, 2012
Filed:
Mar 29, 2007
Appl. No.:
12/301587
Inventors:
Ralph E. Parchment - Hagerstown MD, US
Bhaskara R. Jasti - Stockton CA, US
Ramesh R. Boinpally - Broomfield CO, US
Stephen E. Rose - Flushing MI, US
Earle T. Holsapple - Grosse Pointe Farms MI, US
Bhaskara R. Jasti - Stockton CA, US
Ramesh R. Boinpally - Broomfield CO, US
Stephen E. Rose - Flushing MI, US
Earle T. Holsapple - Grosse Pointe Farms MI, US
Assignee:
SCITECH DEVELOPMENT, LLC - Grosse Pointe Farms MI
WAYNE STATE UNIVERSITY - Detroit MI
WAYNE STATE UNIVERSITY - Detroit MI
International Classification:
A61K 9/14, A61P 35/00, A61P 1/18, A61K 49/18, A61K 49/00, B29B 9/04, A61K 31/167, A61K 51/12, B82Y 5/00
US Classification:
424 129, 424502, 514613, 424 93, 424 96, 264 9, 977797, 977773, 977906
Abstract:
Formulations of neutral retinoids, in particular fenretinide (HPR) in the form of lipid nanoparticles, solid dipersions and emulsions are disclosed. These compositions are used to treat diseases that are amenable to treatment by HPR, such as neoplastic diseases by achieving higher and more prolonged concentrations of HPR in the subject. The key steps for preparing lipid nanovesicles of HPR include mixing and sonication, sterile filtration, without or without lyophilization for long-term stable storage, and employ processes and materials that are scalable from the laboratory to the manufacturing level. The formulation are suitable for injection into human or animal patients without causing allergic or hypersensitivity responses by avoiding chemical surfactants and animal sources of phospholipids in their manufacture.
Methods Of Treating Ocular Disorders
Methods Of Treating Ocular Disorders
US Patent:
2010021, Aug 26, 2010
Filed:
Feb 22, 2010
Appl. No.:
12/710358
Inventors:
XIAOLING LI - Danville CA, US
Bhaskara Jasti - Stockton CA, US
Ravichandran Mahalingam - Stockton CA, US
Bhaskara Jasti - Stockton CA, US
Ravichandran Mahalingam - Stockton CA, US
International Classification:
A61K 38/13, A61K 38/16, A61P 27/02
US Classification:
514 11, 514 12
Abstract:
This invention is directed to treatments of ocular disorders using emulsions and molecular dispersions in the form of a gel comprising a hydrophobic ocular agent.